FDA's Nonprescription Drugs Advisory Committee voted unanimously April 15 to recommend approval of Galderma Laboratories L.P.'s first-in-class OTC switch of adapalene gel 0.1% acne treatment.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?